Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia

Blood

Volumn 96, Issue 10, 2000, Pages 3381-3384

  Gajjar, A ^a   Harrison, P L ^a   Sandlund, J T ^a   Rivera, G K ^a   Ribeiro, R C ^a   Rubnitz, J E ^a   Razzouk, B ^a   Relling, M V ^a   Evans, W E ^a   Boyett, J M ^a   Pui, C H ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLAST CELL; CANCER SURVIVAL; CEREBROSPINAL FLUID EXAMINATION; CHILD; CONTROLLED STUDY; DISEASE COURSE; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT PLANNING;

EID: 0034669987     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.10.3381     Document Type: Article

References (32)

1. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia
2. Biology and treatment of acute lymphoblastic leukemia
3. Analysis of prognostic factors in acute lymphoblastic leukemia
4. United Kingdom Medical Research Council Acute Lymphoblastic Leukemia (UKALL) Trials I-VIII: Clinical features and results of treatment in four groups of children with adverse prognostic features
5. Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: A Children's Cancer Group Report
6. Blasts in CSF with a normal cell count do not justify alteration of therapy for acute lymphoblastic leukemia in remission: A Children's Cancer Group Study
7. Low leukocyte counts with blast cells in cerebro-spinal fluid of children with newly diagnosed acute lymphoblastic leukemia
8. Prognostic significance of cerebrospinal fluid (CSF) lympho-blasts (LB) at diagnosis (dx) in children with acute lymphoblastic leukemia (ALL)
9. Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy
10. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia
11. The clinical and biologic features correlates of coagulopathy in children with acute leukemia
12. Nonparametric estimation from incomplete observations
13. Design and analysis of randomized clinical trials requiring prolonged observations of each patient. I: Introduction and design
14. Design and analysis of randomized clinical trials requiring prolonged observations of each patient. II: Analysis and examples
15. Statistical aspects of the analysis of data from retrospective studies of disease
16. A class of K-sample tests for comparing the cumulative incidence of a competing risk
17. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia
18. Regression models and life tables
19. Biology and pathogenesis of CNS leukemia
20. Prevention and treatment of meningeal leukemia in children
21. The central nervous system in childhood leukemia. I: The arachnoid
22. The leptomeningeal vein. A site of re-entry of leukemic cells into the systemic circulation
23. Neurologic manifestations of leukemia. I: Symptoms due to increased CSF pressure and hemorrhage. II: Involvement of cranial nerves, hypothalamus, spinal cord, and peripheral neuropathy
24. Contamination of cerebrospinal fluid with hematogenous blasts in patients with leukemia
25. What represents pleocytosis in blood-contaminated ('traumatic tap') cerebrospinal fluid in children?
26. Effect on the white cell count of contaminating cerebrospinal fluid with blood
27. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia
28. Acute lymphoblastic leukemia
29. Conscious sedation of pediatric oncology patients for painful procedures: Development and implementation of a clinical practice protocol
30. Ketamine-midazolam versus meperidine-midazolam for painful procedures in pediatric oncology patients
31. Anesthesia for diagnostic and therapeutic procedures in pediatric outpatients